288 related articles for article (PubMed ID: 23468591)
1. The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin.
Grigoriu S; Bond R; Cossio P; Chen JA; Ly N; Hummer G; Page R; Cyert MS; Peti W
PLoS Biol; 2013; 11(2):e1001492. PubMed ID: 23468591
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.
Jin L; Harrison SC
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13522-6. PubMed ID: 12357034
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes.
Huai Q; Kim HY; Liu Y; Zhao Y; Mondragon A; Liu JO; Ke H
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12037-42. PubMed ID: 12218175
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
[TBL] [Abstract][Full Text] [Related]
5. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
Salowe SP; Hermes JD
Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
[TBL] [Abstract][Full Text] [Related]
6. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex.
Ivery MT
Bioorg Med Chem; 1999 Jul; 7(7):1389-402. PubMed ID: 10465413
[TBL] [Abstract][Full Text] [Related]
7. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations.
Kung L; Halloran PF
Transplantation; 2000 Jul; 70(2):327-35. PubMed ID: 10933159
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
9. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants.
Rodríguez A; Roy J; Martínez-Martínez S; López-Maderuelo MD; Niño-Moreno P; Ortí L; Pantoja-Uceda D; Pineda-Lucena A; Cyert MS; Redondo JM
Mol Cell; 2009 Mar; 33(5):616-26. PubMed ID: 19285944
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells.
Wang H; Zhou CL; Lei H; Wei Q
J Biochem; 2010 Feb; 147(2):185-90. PubMed ID: 19880376
[TBL] [Abstract][Full Text] [Related]
11. Quercetin targets the interaction of calcineurin with LxVP-type motifs in immunosuppression.
Zhao Y; Zhang J; Shi X; Li J; Wang R; Song R; Wei Q; Cai H; Luo J
Biochimie; 2016 Aug; 127():50-8. PubMed ID: 27109380
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage.
Uchino H; Ishii N; Shibasaki F
Acta Neurochir Suppl; 2003; 86():105-11. PubMed ID: 14753416
[TBL] [Abstract][Full Text] [Related]
13. Structures of calcineurin and its complexes with immunophilins-immunosuppressants.
Ke H; Huai Q
Biochem Biophys Res Commun; 2003 Nov; 311(4):1095-102. PubMed ID: 14623295
[TBL] [Abstract][Full Text] [Related]
14. A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin.
Wang L; Cheng N; Wang P; Li J; Jia A; Li W; Zhang N; Yin Y; Tong L; Wei Q; Liu G; Li Z; Luo J
J Biol Chem; 2020 Feb; 295(9):2760-2770. PubMed ID: 31941790
[TBL] [Abstract][Full Text] [Related]
15. Only in the presence of immunophilins can cyclosporin and FK506 disrupt in vivo binding of calcineurin A to its autoinhibitory domain yet strengthen interaction between calcineurin A and B subunits.
Chaudhuri B; Stephan C
Biochem Biophys Res Commun; 1995 Oct; 215(2):781-90. PubMed ID: 7488022
[TBL] [Abstract][Full Text] [Related]
16. [Functional analysis of calcineurin-mediated signalling pathway using fission yeast as a model system].
Sugiura R
Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):155-61. PubMed ID: 11915517
[TBL] [Abstract][Full Text] [Related]
17. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.
Brewin J; Mancao C; Straathof K; Karlsson H; Samarasinghe S; Amrolia PJ; Pule M
Blood; 2009 Nov; 114(23):4792-803. PubMed ID: 19770360
[TBL] [Abstract][Full Text] [Related]
18. Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit.
Perrino BA; Wilson AJ; Ellison P; Clapp LH
Eur J Biochem; 2002 Jul; 269(14):3540-8. PubMed ID: 12135494
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of action of cyclosporin A and FK506.
Ho S; Clipstone N; Timmermann L; Northrop J; Graef I; Fiorentino D; Nourse J; Crabtree GR
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S40-5. PubMed ID: 8811062
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A has low potency as a calcineurin inhibitor in cells expressing high levels of P-glycoprotein.
Fakata KL; Elmquist WF; Swanson SA; Vorce RL; Prince C; Stemmer PM
Life Sci; 1998; 62(26):2441-8. PubMed ID: 9651111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
